Nomura Holdings
ACOR

Nomura Holdings’s Acorda Therapeutics ACOR Stock Holding History

Nomura Holdings’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-95
Closed -$307K – 1708
2016
Q1 		$307K Buy
+95
New +$394K ﹤0.01% 1038
2015
Q2 		– Sell
-84
Closed -$335K – 2110
2015
Q1 		$335K Buy
+84
New +$385K ﹤0.01% 1264
2014
Q4 		– Sell
-24
Closed -$96K – 2822
2014
Q3 		$96K Buy
+24
New +$90K ﹤0.01% 2553
2014
Q1 		– Sell
-324
Closed -$1.13M – 2963
2013
Q4 		$1.13M Buy
+324
New +$1.26M 0.01% 939

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nomura Holdings's ACOR Position: Q2 2016 in Review

Nomura Holdings sold out of Acorda Therapeutics (ACOR) in Q2 2016, closing a stake of 95 shares — an estimated $307K sold.

Nomura Holdings first reported a position in ACOR in Q4 2013 and held it in 4 quarters. The position peaked at $1.13M in Q4 2013. 175 funds tracked by Wall St. Rank hold ACOR as of Q2 2016.

  • Nomura Holdings reported no remaining Acorda Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Nomura Holdings sold 95 Acorda Therapeutics shares in Q2 2016, an estimated $307K.
  • Nomura Holdings first reported a position in Acorda Therapeutics in Q4 2013 and held it in 4 quarters.
  • Nomura Holdings's Acorda Therapeutics position peaked at $1.13M in Q4 2013.
  • 175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2016.

Based on Nomura Holdings's 13F filing for Q2 2016, filed 15 Aug 2016.